The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...

Traditional SLT involves using a laser to manipulate the eye's trabecular meshwork, located around the base of the cornea, ...

Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...

Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .

The focus in recent years has shifted to reducing the long-term burden of medical therapy, minimizing the risk of medication ...

Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG. The purpose of this study was to investigate the efficacy ...

Previous studies have shown that a laser treatment called selective laser trabeculoplasty is as effective as eye drops, but ...

At entry, 127 eyes of 69 patients were enrolled in the SLT/MED study. There were 67 eyes (38 patients) in the SLT group and 60 eyes (31 patients) in the medical group at baseline. One hundred eyes ...

Trabeculoplasty can help lower eye pressure by increasing drainage. The approach originally used was argon laser trabeculoplasty (ALT). It involves treating half of the eye's drainage system ...

Alcon introduces Voyager DSLT in US for the treatment for glaucoma and ocular hypertension: Geneva Thursday, February 20, 2025, 14:00 Hrs [IST] Alcon, the global leader in eye car ...